ZBNA
VRTX icon

Zions Bancorporation, National Association’s Vertex Pharmaceuticals VRTX Stock Holding History

Zions Bancorporation, National Association’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Sell
2,341
-4,960
-68% -$2.2M 0.07% 142
2026
Q1 		$3.26M Sell
7,301
-6,457
-47% -$3.01M 0.21% 72
2025
Q4 		$6.24M Buy
13,758
+4,120
+43% +$1.78M 0.29% 56
2025
Q3 		$3.77M Buy
9,638
+9,452
+5,082% +$3.95M 0.19% 87
2025
Q2 		$82.8K Sell
186
-227
-55% -$105K ﹤0.01% 443
2025
Q1 		$200K Buy
+413
New +$192K 0.01% 325

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Zions Bancorporation, National Association's VRTX Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Vertex Pharmaceuticals (VRTX) stake by 68% in Q2 2026, selling an estimated $2.2M and leaving 2,341 shares worth $1.16M. The position accounts for 0.07% of the portfolio, ranked #142.

Zions Bancorporation, National Association first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.24M in Q4 2025. 1,014 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Zions Bancorporation, National Association held 2,341 shares of Vertex Pharmaceuticals worth $1.16M as of Q2 2026.
  • Zions Bancorporation, National Association sold 4,960 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.2M.
  • Vertex Pharmaceuticals made up 0.07% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #142 holding.
  • Zions Bancorporation, National Association first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Vertex Pharmaceuticals position peaked at $6.24M in Q4 2025.
  • 1,014 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.